Skip to main content
. 2016 Mar 27;7(18):26070–26086. doi: 10.18632/oncotarget.8429

Table 2. The sensitivity, specificity and accuracy of the 3 miRNAs panel.

Training and validation set Testing set
Llung adenocarcinoma (82 cases) Control (91controls) Sensitivity Specificity Accuracy Llung adenocarcinoma (36 cases) Control (43controls) sensitivity specificity accuracy
Plasma 3-miRNAs biomarker 75 89 91.50% 97.80% 94.80% 35 41 97.20% 95.30% 96.20%
CEA 26 90 31.70% 98.90% 67.10% 8 43 22.20% 100% 64.60%

CEA as the lung adenocarcinoma biomarker in three sets.